DEXYCU KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexycu Kit, and when can generic versions of Dexycu Kit launch?
Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one NDA. There are six patents protecting this drug.
This drug has thirty-six patent family members in nineteen countries.
The generic ingredient in DEXYCU KIT is dexamethasone. There are thirty-nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexycu Kit
A generic version of DEXYCU KIT was approved as dexamethasone by XSPIRE PHARMA on April 28th, 1983.
Summary for DEXYCU KIT
International Patents: | 36 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 7 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXYCU KIT at DailyMed |

Recent Clinical Trials for DEXYCU KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
EyePoint Pharmaceuticals, Inc. | Phase 4 |
The Eye Institute of West Florida | Phase 4 |
Research Insight LLC | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXYCU KIT
US Patents and Regulatory Information for DEXYCU KIT
DEXYCU KIT is protected by six US patents.
Patents protecting DEXYCU KIT
Dose guides for injection syringe
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF POSTOPERATIVE INFLAMMATION
Use of sustained release dexamethasone in post-cataract surgery inflammation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF POSTOPERATIVE INFLAMMATION
Use of sustained release dexamethasone in post-cataract surgery inflammation
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Dose guides for injection syringe
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Vehicles for delivery of biologically active substances
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Vehicles for delivery of biologically active substances
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for DEXYCU KIT
See the table below for patents covering DEXYCU KIT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Portugal | 2701773 | See Plans and Pricing | |
South Korea | 101978235 | See Plans and Pricing | |
Poland | 2701773 | See Plans and Pricing | |
South Korea | 20190042765 | 주사기용 투여량 가이드 (DOSE GUIDES FOR INJECTION SYRINGE) | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 03099163 | See Plans and Pricing | |
Japan | 6215193 | See Plans and Pricing | |
Japan | 2014521372 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DEXYCU KIT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1429780 | 13C0012 | France | See Plans and Pricing | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
1581193 | SPC/GB12/047 | United Kingdom | See Plans and Pricing | PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727 |
1429780 | SPC/GB12/058 | United Kingdom | See Plans and Pricing | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |